Angusta 25 ug, Tabletten

7680675800018 CH-67580 Tabletten

Associated product:

ANGUSTA cpr 25 mcg 8 pce
Angusta 25 ug, Tabletten
Angusta 25 ug, Tabletten
Angusta 25 ug, Tabletten
1 / 3
google

Article details

Package size
8
Selling units
8
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
30/12/2022
Patient information leaflet
Français
30/12/2022
Patient information leaflet
Italien
30/12/2022
Summary of Product Characteristics
Allemand
15/03/2022
Summary of Product Characteristics
Français
15/03/2022
Summary of Product Characteristics
Italien
15/03/2022

Detailed composition

Substance Quantity Type Category
(N/A)
0.025 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.87 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

Norgine AG

6005 Luzern

Authorization information

Swissmedic authorization number
67580
Drug name
Angusta, Tabletten
Galenic form
TAB
ATC Code
G02AD06
Authorization status
Z
Dispensing category
B
First authorization
10/01/2022
Authorization expiration date
09/01/2027
IT Number
09.01.1.
Domain
Human medicine
Field of application
Geburtseinleitung

Package details

Description (FR)
ANGUSTA cpr 25 mcg 8 pce
Description (DE)
ANGUSTA Tabl 25 mcg 8 Stk
Market launch
10/01/2022
Narcotic (BTM)
No